183 related articles for article (PubMed ID: 36710133)
1. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting.
Moore CM; King LE; Withington J; Amin MB; Andrews M; Briers E; Chen RC; Chinegwundoh FI; Cooperberg MR; Crowe J; Finelli A; Fitch MI; Frydenberg M; Giganti F; Haider MA; Freeman J; Gallo J; Gibbs S; Henry A; James N; Kinsella N; Lam TBL; Lichty M; Loeb S; Mahal BA; Mastris K; Mitra AV; Merriel SWD; van der Kwast T; Van Hemelrijck M; Palmer NR; Paterson CC; Roobol MJ; Segal P; Schraidt JA; Short CE; Siddiqui MM; Tempany CMC; Villers A; Wolinsky H; MacLennan S
Eur Urol Oncol; 2023 Apr; 6(2):160-182. PubMed ID: 36710133
[TBL] [Abstract][Full Text] [Related]
2. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.
Moore CM; Giganti F; Albertsen P; Allen C; Bangma C; Briganti A; Carroll P; Haider M; Kasivisvanathan V; Kirkham A; Klotz L; Ouzzane A; Padhani AR; Panebianco V; Pinto P; Puech P; Rannikko A; Renard-Penna R; Touijer K; Turkbey B; van Poppel H; Valdagni R; Walz J; Schoots I
Eur Urol; 2017 Apr; 71(4):648-655. PubMed ID: 27349615
[TBL] [Abstract][Full Text] [Related]
3. Compliance Rates with the Prostate Cancer Research International Active Surveillance (PRIAS) Protocol and Disease Reclassification in Noncompliers.
Bokhorst LP; Alberts AR; Rannikko A; Valdagni R; Pickles T; Kakehi Y; Bangma CH; Roobol MJ;
Eur Urol; 2015 Nov; 68(5):814-21. PubMed ID: 26138043
[TBL] [Abstract][Full Text] [Related]
4. A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer-Data from the International Multicenter Prospective PRIAS Study.
Luiting HB; Remmers S; Boevé ER; Valdagni R; Chiu PK; Semjonow A; Berge V; Tully KH; Rannikko AS; Staerman F; Roobol MJ
Eur Urol Oncol; 2022 Dec; 5(6):651-658. PubMed ID: 35437217
[TBL] [Abstract][Full Text] [Related]
5. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
6. A Decade of Active Surveillance in the PRIAS Study: An Update and Evaluation of the Criteria Used to Recommend a Switch to Active Treatment.
Bokhorst LP; Valdagni R; Rannikko A; Kakehi Y; Pickles T; Bangma CH; Roobol MJ;
Eur Urol; 2016 Dec; 70(6):954-960. PubMed ID: 27329565
[TBL] [Abstract][Full Text] [Related]
7. Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy.
Willemse PM; Davis NF; Grivas N; Zattoni F; Lardas M; Briers E; Cumberbatch MG; De Santis M; Dell'Oglio P; Donaldson JF; Fossati N; Gandaglia G; Gillessen S; Grummet JP; Henry AM; Liew M; MacLennan S; Mason MD; Moris L; Plass K; O'Hanlon S; Omar MI; Oprea-Lager DE; Pang KH; Paterson CC; Ploussard G; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TBL
Eur Urol; 2022 Apr; 81(4):337-346. PubMed ID: 34980492
[TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Imaging-Guided Confirmatory Biopsy for Initiating Active Surveillance of Prostate Cancer.
Jayadevan R; Felker ER; Kwan L; Barsa DE; Zhang H; Sisk AE; Delfin M; Marks LS
JAMA Netw Open; 2019 Sep; 2(9):e1911019. PubMed ID: 31509206
[TBL] [Abstract][Full Text] [Related]
9. A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance.
Merriel SWD; Moon D; Dundee P; Corcoran N; Carroll P; Partin A; Smith JA; Hamdy F; Moore C; Ost P; Costello T
BMC Urol; 2021 Feb; 21(1):18. PubMed ID: 33541309
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
[TBL] [Abstract][Full Text] [Related]
11. Refined Analysis of Prostate-specific Antigen Kinetics to Predict Prostate Cancer Active Surveillance Outcomes.
Cooperberg MR; Brooks JD; Faino AV; Newcomb LF; Kearns JT; Carroll PR; Dash A; Etzioni R; Fabrizio MD; Gleave ME; Morgan TM; Nelson PS; Thompson IM; Wagner AA; Lin DW; Zheng Y
Eur Urol; 2018 Aug; 74(2):211-217. PubMed ID: 29433975
[TBL] [Abstract][Full Text] [Related]
12. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.
Stavrinides V; Giganti F; Trock B; Punwani S; Allen C; Kirkham A; Freeman A; Haider A; Ball R; McCartan N; Whitaker H; Orczyk C; Emberton M; Moore CM
Eur Urol; 2020 Sep; 78(3):443-451. PubMed ID: 32360049
[TBL] [Abstract][Full Text] [Related]
13. PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
Englman C; Maffei D; Allen C; Kirkham A; Albertsen P; Kasivisvanathan V; Baroni RH; Briganti A; De Visschere P; Dickinson L; Gómez Rivas J; Haider MA; Kesch C; Loeb S; Macura KJ; Margolis D; Mitra AM; Padhani AR; Panebianco V; Pinto PA; Ploussard G; Puech P; Purysko AS; Radtke JP; Rannikko A; Rastinehad A; Renard-Penna R; Sanguedolce F; Schimmöller L; Schoots IG; Shariat SF; Schieda N; Tempany CM; Turkbey B; Valerio M; Villers A; Walz J; Barrett T; Giganti F; Moore CM
Eur Urol; 2024 Mar; ():. PubMed ID: 38556436
[TBL] [Abstract][Full Text] [Related]
14. Risk-stratification based on magnetic resonance imaging and prostate-specific antigen density may reduce unnecessary follow-up biopsy procedures in men on active surveillance for low-risk prostate cancer.
Alberts AR; Roobol MJ; Drost FH; van Leenders GJ; Bokhorst LP; Bangma CH; Schoots IG
BJU Int; 2017 Oct; 120(4):511-519. PubMed ID: 28267899
[TBL] [Abstract][Full Text] [Related]
15. Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement.
Merriel SWD; Hetherington L; Seggie A; Castle JT; Cross W; Roobol MJ; Gnanapragasam V; Moore CM;
BJU Int; 2019 Jul; 124(1):47-54. PubMed ID: 30742733
[TBL] [Abstract][Full Text] [Related]
16. [Active surveillance for low-risk prostate cancer].
Herlemann A; Stief CG
Urologe A; 2016 Feb; 55(2):269-81. PubMed ID: 26831055
[TBL] [Abstract][Full Text] [Related]
17. Focal therapy: patients, interventions, and outcomes--a report from a consensus meeting.
Donaldson IA; Alonzi R; Barratt D; Barret E; Berge V; Bott S; Bottomley D; Eggener S; Ehdaie B; Emberton M; Hindley R; Leslie T; Miners A; McCartan N; Moore CM; Pinto P; Polascik TJ; Simmons L; van der Meulen J; Villers A; Willis S; Ahmed HU
Eur Urol; 2015 Apr; 67(4):771-7. PubMed ID: 25281389
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy.
Vasarainen H; Lahdensuo K; Savolainen R; Ruutu M; Taari K; Rannikko A
Scand J Urol; 2013 Dec; 47(6):456-61. PubMed ID: 23327661
[TBL] [Abstract][Full Text] [Related]
19. Active surveillance strategy for patients with localised prostate cancer: criteria for progression.
Thomsen FB
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634510
[TBL] [Abstract][Full Text] [Related]
20. PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design.
Ahlberg MS; Adami HO; Beckmann K; Bertilsson H; Bratt O; Cahill D; Egevad L; Garmo H; Holmberg L; Johansson E; Rannikko A; Van Hemelrijck M; Jäderling F; Wassberg C; Åberg UWN; Bill-Axelson A
BMJ Open; 2019 Aug; 9(8):e027860. PubMed ID: 31444180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
